“The National Institute for Health and Clinical Excellence (NICE) has issued new guidance recommending use of Acomplia® (rimonabant) in England and Wales, within its licensed indications, as an adjunct to diet and exercise for adults who are obese or overweight and who have had an inadequate response to, are intolerant of or are contraindicated to other anti-obesity agents that have previously been reviewed by NICE. The NICE guidance on Acomplia® comes as new national survey data released today shows that three quarters of Britons think GPs should help obese patients lose weight, if they are at risk of associated diseases and have already unsuccessfully tried diet and exercise. Dr David Haslam, Clinical Director of the National Obesity Forum welcomed the new NICE guidance. He said: ‘Obesity is a chronic disease that places a significant burden on society as well as an individual, so it is vital GPs have a full range of options to help treat obese and overweight patients especially those with associated risk factors such as type 2 diabetes. Trials show that Acomplia®, in addition to diet and physical activity, provides clinically meaningful weight loss and improvements in related risk factors, such as better blood sugar control.’”
http://www.medicalnewstoday.com/articles/112616.php
Subscribe to:
Post Comments (Atom)
1 comment:
nice article on Obesity treatment,
thanksf for sharing information
Post a Comment